— Know what they know.
Not Investment Advice

VIR NASDAQ

Vir Biotechnology, Inc.
1W: -0.7% 1M: -15.4% 3M: +19.4% YTD: +52.0% 1Y: +90.9% 3Y: -63.7% 5Y: -78.6%
$9.19
+0.16 (+1.77%)
 
Weekly Expected Move ±6.8%
$8 $8 $9 $9 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 34 · $1.5B mcap · 129M float · 2.72% daily turnover · Short 56% of daily vol

📊 Key Metrics

TTM
$65M
Revenue
+214.0% YoY
$-443M
Net Income
+23.4% YoY
$-445M
Free Cash Flow
-5.4% YoY
9793.1%
Gross Margin
459241.4%
Op. Margin
433431.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-46.2%
ROA-36.9%
ROIC-74.5%

Valuation

P/E-3.0
P/B1.7
EV/EBITDA-2.3

Leverage

Debt/Equity0.24
Current Ratio5.54
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z0.73
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms